UPDATE: TJX Cos. (TJX) Tops Q2 EPS by 3c; Guides Q3, Boosts FY13 Outlook
Tweet
Share
E-mailGet Alerts TJX Hot Sheet
Price: $130.19 -1.43%
Revenue Growth %: +5.0%
Financial Fact:
Cash dividends declared per share: 0.26
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.0%
Financial Fact:
Cash dividends declared per share: 0.26
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
(Updated - August 20, 2013 8:27 AM EDT)
TJX Cos. (NYSE: TJX) reported Q2 EPS of $0.66, $0.03 better than the analyst estimate of $0.63. Revenue for the quarter came in at $6.44 billion versus the consensus estimate of $6.37 billion.
TJX Cos. sees Q3 2013 EPS of $0.69 - $0.72, versus the consensus of $0.71. Sees comps up 2 - 3 percent.
The retailer also boosted FY13 expectations. EPS now expected to be $2.74 - $2.80, from $2.70 - $2.78 and estimates of $2.82.
For earnings history and earnings-related data on TJX Cos. (TJX) click here.
TJX Cos. (NYSE: TJX) reported Q2 EPS of $0.66, $0.03 better than the analyst estimate of $0.63. Revenue for the quarter came in at $6.44 billion versus the consensus estimate of $6.37 billion.
TJX Cos. sees Q3 2013 EPS of $0.69 - $0.72, versus the consensus of $0.71. Sees comps up 2 - 3 percent.
The retailer also boosted FY13 expectations. EPS now expected to be $2.74 - $2.80, from $2.70 - $2.78 and estimates of $2.82.
For earnings history and earnings-related data on TJX Cos. (TJX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- CANEX Increases Equity Financing to C$9 Million
- Labcorp acquires MLM Medical Labs to expand lab network
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Guidance, Retail SalesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
